You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

Fintel reports that on October 20, 2025, JP Morgan upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underweight to Neutral. Analyst Price Forecast Suggests 18.55% Downside As of ...

Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in UnitedHealth Group Inc (Symbol: UNH), where a total volume of 92,988 contracts has ...

Replimune Group (REPL) has drawn attention after presenting updated clinical data from its IGNYTE phase 2 trial at the ESMO Congress 2025. The study combined RP1 with nivolumab in patients with acral ...

In a report released today, Peter Lawson from Barclays maintained a Hold rating on Replimune Group, with a price target of $3.00. The company’s shares closed yesterday at $8.95. Take advantage of ...

We list the best Python online courses, to make it simple and easy for coders of various levels to evolve their skills with accessible tutorials. Python is one of the most popular high-level, ...

On June 3, 2025, in Borneo, Indonesia, dramatic footage showed a 20-foot python coiling around a tour guide's neck during a swamp capture. The snake catcher, identified as Heru, was pulled into the ...